CIK 0001576885 · <br>Emerging growth company
Acumen Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ABOS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364108129
- Phone
- 617-344-4190
- Business address
- 1210-1220 WASHINGTON STREET, SUITE 210, NEWTON, MA, 02465
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-04 | Ives Jeffrey L. Director | Grant or award | +12,800 | 12,800 | ||
| 2025-06-04 | Ives Jeffrey L. Director | Grant or award · Stock Option (right to buy) | +19,500 | 19,500 | ||
| 2025-06-04 | Porter Derrell Director | Grant or award | +12,800 | 12,800 | ||
| 2025-06-04 | Porter Derrell Director | Grant or award · Stock Option (right to buy) | +19,500 | 19,500 | ||
| 2025-06-04 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award | +12,800 | 12,800 | ||
| 2025-06-04 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award · Stock Option (Right to Buy) | +19,500 | 19,500 | ||
| 2025-01-23 | Zuga Matt CFO & Chief Business Officer | Sale 10b5-1 | −28,902 | $1.72 | $50K | 231,744 |
| 2025-01-21 | Zuga Matt CFO & Chief Business Officer | Sale 10b5-1 | −4,364 | $1.60 | $7K | 260,646 |
| 2025-01-21 | OConnell Daniel Joseph Chief Executive Officer | Sale 10b5-1 | −12,619 | $1.59 | $20K | 667,488 |
| 2025-01-21 | Meisner Derek M Chief Legal Officer & Corp Sec | Sale 10b5-1 | −3,418 | $1.59 | $5K | 161,127 |
| 2025-01-21 | Barton Russell Chief Operating Officer | Sale 10b5-1 | −2,914 | $1.61 | $5K | 136,117 |
| 2025-01-21 | Siemers Eric Chief Medical Officer | Sale 10b5-1 | −3,219 | $1.59 | $5K | 170,298 |
| 2025-01-07 | OConnell Daniel Joseph Chief Executive Officer | Grant or award 10b5-1 | +225,400 | 680,107 | ||
| 2025-01-07 | OConnell Daniel Joseph Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) 10b5-1 | +338,000 | 338,000 | ||
| 2025-01-06 | Schacterle Amy Chief Regulatory Officer | Grant or award | +8,800 | 8,800 | ||
| 2025-01-06 | Schacterle Amy Chief Regulatory Officer | Grant or award · Employee Stock Option (right to buy) | +13,200 | 13,200 | ||
| 2025-01-06 | Doherty James J. President and CDO | Grant or award | +62,600 | 62,600 | ||
| 2025-01-06 | Doherty James J. President and CDO | Grant or award · Employee Stock Option (right to buy) | +93,300 | 93,300 | ||
| 2025-01-06 | Meisner Derek M Chief Legal Officer & Corp Sec | Grant or award 10b5-1 | +66,800 | 164,545 | ||
| 2025-01-06 | Meisner Derek M Chief Legal Officer & Corp Sec | Grant or award · Employee Stock Option (right to buy) 10b5-1 | +100,300 | 100,300 |
Page 6 of 13 · 246 trades